首页> 外文期刊>The Journal of Urology >The effects of colchicine on a Peyronie's-like condition in an animal model.
【24h】

The effects of colchicine on a Peyronie's-like condition in an animal model.

机译:秋水仙碱对动物模型中类似佩罗尼氏症的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: We have developed an animal model of Peyronie's disease by injecting transforming growth factor beta (TGF-beta) into the rat penis. Our objective is to study the effects of colchicine on the Peyronie's condition in an animal model. MATERIALS AND METHODS: Thirty-six adult male Sprague-Dawley rats received TGF-beta injections into the tunica albuginea and were divided into two groups (n = 18 each). Rats in the first group were divided into three subgroups (n = 6 each). Each rat in the three subgroups received the following: Subgroup 1 received colchicine, subgroup 2 received ibuprofen, and subgroup 3 received regular water. The rats were euthanized after 6 weeks. Rats in the second group were also divided into three subgroups. These rats received the same treatments as the rats in the first group, but treatments began 6 weeks after TGF-beta injection. These rats were euthanized after 12 weeks. Tunical tissue samples were collected and examined using Hart and trichrome stains, electron microscopy (EM), and western blot analysis for TGF-beta detection. RESULTS: In the first group, the colchicine-treated rats exhibited less collagen deposition and less elastic fiber fragmentation than the untreated or ibuprofen-treated rats. EM confirmed the results and showed normal distribution and shape of both collagen and elastic fibers in the colchicine-treated group. In the second group, the colchicine-treated rats exhibited less crowding of the collagen fibers. However, the elastic fibers remained fragmented and scarce. Western blot analysis showed significant down-regulation of TGF-beta expression (5/6) in the colchicine-treated group after 6 weeks. Down-regulation was observed in only 1/6 in both ibuprofen and non-treated groups. After 12 weeks 2/6, 1/6, and 1/6 rats displayed down regulation in the colchicine treated, ibuprofen treated, and non-treated groups, respectively. CONCLUSION: Early colchicine treatment may suppress a Peyronie's like condition in the rat animal model.
机译:目的:我们通过将转化生长因子β(TGF-beta)注射到大鼠阴茎中,建立了佩罗尼氏病的动物模型。我们的目的是在动物模型中研究秋水仙碱对佩罗尼氏病的影响。材料与方法:36只成年雄性Sprague-Dawley大鼠接受TGF-beta注射入白膜,分为两组(每组18只)。第一组中的大鼠分为三个亚组(每组n = 6)。三个亚组中的每只大鼠均接受以下药物:亚组1接受秋水仙碱,亚组2接受布洛芬,亚组3接受常规水。 6周后对大鼠实施安乐死。第二组中的大鼠也分为三个亚组。这些大鼠接受与第一组相同的治疗,但是在注射TGF-β后6周开始治疗。在12周后对这些大鼠实施安乐死。收集上皮组织样本,并使用Hart和三色染色剂,电子显微镜(EM)和Western印迹分析进行TGF-beta检测。结果:在第一组中,秋水仙碱治疗的大鼠比未治疗或布洛芬治疗的大鼠表现出更少的胶原蛋白沉积和更少的弹性纤维断裂。 EM证实了结果,并显示秋水仙碱治疗组的胶原蛋白和弹性纤维均呈正态分布和形状。在第二组中,秋水仙碱处理的大鼠表现出较少的胶原纤维拥挤。但是,弹性纤维仍然破碎和稀缺。 Western印迹分析显示秋水仙碱治疗组在6周后TGF-β表达显着下调(5/6)。在布洛芬和未治疗组中仅观察到下调的1/6。 12周后,在秋水仙碱治疗组,布洛芬治疗组和非治疗组中,分别有2 / 6、1 / 6和1/6大鼠表现出下调。结论:秋水仙碱的早期治疗可能会抑制大鼠动物模型中的Peyronie病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号